MTN Zambia is targeting growth in 2018 through the delivery of services and products that are relevant and affordable for its customers. This will see the company continue to invest in its operations to ensure customer satisfaction for its range of services that include mobile money and data services.
Speaking in Lusaka yesterday, MTN Chief Executive Officer Charles Molapisi said the company will focus on delivering superior customer experiences and in line with this, has committed 2018 to being the ‘Year of the Customer.’
“As the year comes to a close, MTN is looking ahead to 2018 and building on the momentum of this year to continue with the delivery of industry leading services and products to our customers. 2018 is our ‘Year of the Customer’ and ahead of this exciting journey next year, we are today announcing significant data price slash because we believe in increasing access to affordable data and enhance connectivity for customers,” said Molapisi.
“During the course of the year, we have significantly brought down the cost of access to our different products and services. MTN has taken a deliberate step towards dedicating 2018 to our customers and we have undertaken this decision to reduce our data rates as a reward to our customers, giving them affordable data and savings as the year comes to a close.”
He added that MTN is committed to delivering affordable data services and will continue delivering industry-leading, affordable data across Zambia, making it easy for customers to choose bundles or price plans that are relevant to customer needs and affordability.
“This is an end of year offer, rewarding our customers with discounts and we’re giving them massive savings on data while offering value-added services such as MTN TV Plus and MTN Music Plus,” he said.
The price slash comes ahead of MTN’s commitment to make 2018 the ‘Year of the Customer’ with its customer-facing solutions to financial inclusion, connectivity and access to information.
“We are really focusing on our customers next year and this is our launch pad for solutions and services that place our customers first, giving them real value to being on Zambia’s number one network and internet leader,” he said.
MTN is not only taking the lead with data solutions in Zambia but investing in ensuring nationwide connectivity including rural areas. The company has invested in fibre network that runs from Lusaka to Nakonde, Kalumbila in North-Western province and in Ndola.
“When we talk about reducing prices on data, we’re backing this up with real, industry leading services. We are working to deliver internet access closer to the people and we will continue to review our price points to ensure that our customers benefit from our investment in data,” he said.
The company’s investment in underground fibre links forms part of MTN’s plan to connect every international border with Zambia to the network.
Vehicles in Zambia increased to 853,909, RTSA, Police say
Zambia allocated 8.7 million doses of COVID-19 vaccines
ZAMBIA has been allocated 8.7million doses of Covid-19 vaccines under a facility being pioneered by the Africa Union.
Zambia’s Ambassador to Ethiopia and Permanent Representative to the African Union, His Excellency Emmanuel Mwamba announced the development.
He said the initiative is being done under the COVID-19 African Vaccine Acquisition Task Team (AVATT) a platform which has been created to ensure that upto 60% of Africa’s population were vaccinated against the Coronavirus by December 2021.
He said AVATT was created by President Cyril Ramaphosa, Chairperson of the African Union, in November 2020.
He said AVATT has been mandated to secure the necessary vaccines and blended financing resources for achieving Africa’s COVID-19 vaccination strategy which targets vaccinating a minimum of 60 per cent of Africa’s population.
Mr. Mwamba said AVATT’s efforts are focused on; securing enough safe and efficacious vaccine doses to vaccinate at least 60 per cent of the African population, estimating the funding needs for vaccine procurement and delivery and creating the financing mechanisms required to ensure that all African Union Member States can access and receive the vaccine doses they need to reach a minimum of 60 per cent immunisation.
He said under the mechanism, the vaccines are being sourced from Pfizer, Johnson and Johnson, and AstraZeneca.
Pfizer and Johnsons &Johnsons are among the world’s largest pharmaceutical companies, while AstraZeneca PLC is a British-Swedish multinational pharmaceutical.
He said a finance facility has been created under the AVATT- the Advance Procurement Commitment (APC) Facility to be backed by African Import and Export Bank (Afreximbank).
He said this mechanism aims at ensuring Africa’s access to the COVID-19 vaccines from no later than April 2021, by providing assurance to identified vaccine manufacturers that vaccine orders placed through the African Medical Supplies Platform (AMSP), are firm and will be paid for as may be agreed.
APC aims to guarantee Africa’s access to of COVID-19 vaccines in a manner that reduces the fiscal burden on member countries.
The mechanism will also ensure a timely, equitable and cost-effective availability of COVID-19 vaccine supplies within the African continent and by so doing, mitigate the protracted financial and socio-economic costs of the COVID-19.
This is also to provide a credible platform around which a blend of funding can be attached to
support Africa’s COVID-19 vaccine procurement requirements.
The Task Team has provisionally secured 270 million vaccine doses for Africa for the critical period from April to December 2021.
He said Zambia’s allocation may rise to 25million doses by December 2021.
These vaccine doses, which are in addition to the expected COVAX doses, will be distributed through the African Medical Supplies Platform (AMSP).
The candidates and related quantities are; 50 million doses of the Pfizer/BioNTech vaccine, 100million doses of the AstraZeneca vaccine, through the Serum Institute of India and 120 million doses of the Johnson and Johnson vaccine (upon satisfactory conclusion of phase III trials).
He said the vaccines will obtain prior approval by AVATT on the recommendation of the Africa-CDC.
Africa CDC will approve the vaccines having considered the necessary conditions, efficacy including vaccines which have been trialed in Africa and safety.
Mr. Mwamba said the Permanent Representative Committee (PRC) was briefed of the progress that has been made to ensure that member states began to receive the vaccines from March- April 2021.
This is according to issued by Mrs. Inutu Mupango Mwanza First Secretary (Press&Tourism), Addis Ababa,Ethiopia